Despite the growth of open access publishing, there is still a massive and growing archive of peer-reviewed research that is hidden behind paywalls. While academics can reach most of the research they need through library subscriptions, researchers, professionals and the broader community outside of academia are effectively cut off from the vast majority of peer-reviewed … Continue reading Guerilla open access, public engagement with research, and ivory towers
Over the short break that divided 2013 and 2014, we had a new study published looking at the designs of neuropsychiatric clinical trials that involve children. Because we study trial registrations and not publications, many of the trials that are included in the study are yet to be published, and it is likely that quite a … Continue reading Neuropsych trials involving kids are designed differently when funded by the companies that make the drugs
I asked a question on Twitter about whether or not people actually tried to read the peer-reviewed journal articles (not just the media releases), and if they encountered paywalls when they tried. This is what happened: [Click on the time/date to see the conversation] In case you don't want to read through the whole conversation, … Continue reading Do people outside of universities want to read peer-reviewed journal articles?
I've taken a little while to get this post done because I've been waiting for my recently-published article to go from online-first to being citeable with volume and page numbers. Last year, I was asked to write an editorial on the topic of industry influence on clinical evidence for the Journal of Epidemiology & Community Health, … Continue reading Introducing evidence surveillance as a research stream
Guy Tsafnat, me, Paul Glasziou and Enrico Coiera have written an editorial for the BMJ on the automation of systematic reviews. I helped a bit, but the clever analogy with the ticking machines from Player Piano fell out of Guy's brain. In the editorial, we covered the state-of-the-art in automating specific tasks in the process of synthesising … Continue reading How about a systematic review that writes itself?
I co-wrote a piece for The Conversation about a new article that was published in the Cochrane Database of Systematic Reviews, written by Andreas Lundh and other luminaries from the research area. The authors showed that industry sponsored clinical trials more often report positive outcomes and fewer harmful side effects. The most interesting result from … Continue reading Dealing with industry’s influence on clinical evidence